Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica. 2024 Sep 1;109(9):2998-3003. doi: 10.3324/haematol.2023.284179.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Neutralizing
  • Female
  • Humans
  • Lymphohistiocytosis, Hemophagocytic* / diagnosis
  • Lymphohistiocytosis, Hemophagocytic* / drug therapy
  • Lymphohistiocytosis, Hemophagocytic* / etiology
  • Male
  • Middle Aged
  • Neoplasms / complications
  • Neoplasms / drug therapy
  • Salvage Therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Emapalumab
  • Antibodies, Neutralizing